Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Endocardial Solutions was a medical technology company specializing in the development of advanced cardiac mapping and navigation systems. The company's flagship product, the EnSite System, provided 3D visualization of the heart's electrical activity to assist electrophysiologists in diagnosing and treating complex cardiac arrhythmias. By utilizing non-contact mapping technology, the system allowed for the creation of detailed voltage maps without the need for extensive catheter manipulation. This innovation significantly improved the efficiency and accuracy of catheter ablation procedures for conditions like atrial fibrillation. The company was acquired by St. Jude Medical in 2005 for approximately $273 million. Its technology remains a cornerstone of the electrophysiology market, now operating under Abbott following its acquisition of St. Jude Medical.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Endocardial Solutions.